- Lobbying
- Tom AND Wharton
Lobbying Arrangements Results for 'Tom Wharton'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Low Carb Low carb in DGA Low Carb in DGA |
Low Carb Action Network
|
GORDLEY ASSOCIATES | |||
Details S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit ... |
Coherus BioSciences, Inc
|
INLET STRATEGIES | |||
Details Reducing Improper Payments in Medicaid and Medicare; Electronic Visit Verification. |
HealthStar, LLC
|
CAPITOL HILL CONSULTING GROUP | |||
Details EPA Regulatory Approval. CARES Act implementation. Regulatory Approved for Health Related Tech. Issues related to coronavirus response. |
Allied BioScience, Inc.
|
CAPITOL HILL CONSULTING GROUP | |||
Details Maintaining US support for quality pharmaceutical standards. Issues related to coronavirus, including drug and supply chain safety. Issues related to continuous manufacturing. |
United States Pharmacopeial Convention (USP)
|
CAPITOL HILL CONSULTING GROUP | |||
Details Access to mental health care and Centers for Medicare and Medicaid Services payment policy. Access to mental health care and Centers for Medicare and Medicaid Services payment policy. Issues relate... |
BRE Program Administrative Services, LLC
|
CAPITOL HILL CONSULTING GROUP | |||
Details Medicare and Medicaid reimbursement issues. |
TriSalus Life Sciences
|
CAPITOL HILL CONSULTING GROUP | |||
Details Medicare reimbursement and coverage of chiropractic services, including H.R.1610 and S.799. Issues related to coronavirus, including regulatory flexibility for providers. Issues related to expandin... |
American Chiropractic Association, Inc.
|
CAPITOL HILL CONSULTING GROUP | |||
Details Issues related to H.R. 1634 / S. 1367 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act Issues related to therapeutic shoes. Issues regarding physician reimbursement ... |
American Podiatric Medical Association
|
CAPITOL HILL CONSULTING GROUP | |||
Details Issues related to coverage under the Affordable Care Act Issues related to cardiac rehabilitation coverage, including HR 3911 and S. 2842. Issues related to coronavirus, including regulatory flexib... |
American Heart Association
|
CAPITOL HILL CONSULTING GROUP | |||
Details Implementation of Tax Reform, international tax proposals related to intellectual property. Issues related to Biosimilar Approvals and implementation of biologic price competition and innovation ac... |
NOVARTIS CORPORATION
|
CAPITOL HILL CONSULTING GROUP | |||
Details Issues related to hospital reimbursement during Covid-19 pandemic. Issues related to Graduate Medical Education including H.R.2389. Issues related to price transparency. Issues related to coronavir... |
Association of American Medical Colleges
|
CAPITOL HILL CONSULTING GROUP | |||
Details Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Issues surrounding the BETTER Kidney Care Act. Medicare reimbursement and Medicare Secondary Payer policies, inclu... |
DaVita Inc
|
CAPITOL HILL CONSULTING GROUP | |||
Details Medicare advantage payment policy. Issues related to the federal response to Covid-19. Issues pertaining to entitlement reform, Medicare Advantage, Medicaid Dual Eligibles, and Medicare reimburseme... |
CVS previously Aetna
|
CAPITOL HILL CONSULTING GROUP | |||
Details Medicare and Medicaid reimbursement for biosimilars, including for domestically manufactured biosimilars. Issues relating to the impact of prescription drug negotiation on biosimilars. Issues surro... |
Coherus BioSciences, Inc
|
CAPITOL HILL CONSULTING GROUP | |||
Details Monitoring for issues and hearing related to prevention of abuse, misuse or diversion of prescription drugs; federal response to the COVID-19 crisis; prescription drug payment reform; and pharmaceu... |
PURDUE PHARMA, LLP
|
CAPITOL HILL CONSULTING GROUP | |||
Details Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. Issues relate... |
Teva Pharmaceuticals USA
|
CAPITOL HILL CONSULTING GROUP | |||
Details - Issues relating to the labeling of generic drugs. - Issues relating to the 180 day exclusivity for generics. - Issues related to medical supply chain, including supply chain safety. - Issues rela... |
Association for Accessible Medicines (Formerly Generic Pharmaceutical Assoc.)
|
CAPITOL HILL CONSULTING GROUP | |||
Details Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to FDA approvals of new drugs and generic drugs. Issues related to the F... |
Endo Pharmaceuticals
|
CAPITOL HILL CONSULTING GROUP | |||
Details Insulin Out of Pocket Costs; Covid Therapeutics; Generics Access; Gene Therapy S. 150 - Affordable Prescriptions for Patients Act of 2023 A bill to amend the Federal Trade Commission Act to prohi... |
Blue Cross and Blue Shield Association
|
in-house lobbying | |||
Details FY24 Interior Appropriations (H.R. 4821/S. 2605) Advisory Council on Historic Preservation (ACHP) - Various issues related to implementation of National Historic Preservation Act and National Envir... |
National Trust for Historic Preservation
|
in-house lobbying |